ContextVision’s Deep Learning experts will hold an oral presentation at the Medical Imaging & Deep Learning conference in London July 8–10

This paper presents an interesting and novel idea of a deep learning (DL) framework to segment potentially cancerous areas in prostate biopsies using semi-automatically generated data. The application of this paper is quite innovative and the proposed method seems to be a direct assistance to the clinical routine.
Read More

ContextVision sees strong sales, continues focus on launch of AI-based digital pathology

ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, reported strong sales in Q1, reaching 21.1 MSEK, 9% higher than the first quarter last year. The company reports positive feedback from user tests within digital pathology and continues to proceed with product development for this fast-growing market.
Read More

ContextVision on track for 2019 commercial product launch within digital pathology

STOCKHOLM – February 21, 2019 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is closing in on a commercial product within digital pathology with a planned launch in 2019. Tests prove that ContextVision’s algorithms perform as well as pathologists and have also helped identify suspicious cancer areas that are […]
Read More

ContextVision to showcase Altumira(TM), AI-powered image enhancement for digital radiography at ECR 2019

With deep learning technology integrated, Altumira is specially designed to meet the demanding needs of digital radiography for both dynamic and static X-ray. At ECR, the full suite of industry-leading image enhancement products for ultrasound will be showcased. ContextVision's products deliver unsurpassed image quality for all types of ultrasound systems from handheld devices to the most advanced 3D/4D applications.
Read More